Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peroral Endoscopic Cardial Constriction vs Omeprazole in Elderly GERD
ChiCTR2500098430Phase 2Not yet recruiting
- Sponsor
- Suining Central Hospital
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of omeprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Suining Central Hospital. Primary endpoints: Gastroesophageal reflux disease questionnaire score, Los Angeles Classification (LA) for esophagitis and 6 more. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on ChiCTR2500098430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098430.